Hepatic Tristetraprolin Promotes Insulin Resistance Through RNA Destabilization of FGF21

JCI insight - United States
doi 10.1172/jci.insight.95948
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells

Cancer Research and Treatment
Cancer ResearchOncology
1970English

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

Hepatology
MedicineHepatology
2018English

Insulin Receptor Thr1160 Phosphorylation Mediates Lipid-Induced Hepatic Insulin Resistance

Journal of Clinical Investigation
Medicine
2016English

Liver-Specific G0 /G1 Switch Gene 2 (G0s2) Expression Promotes Hepatic Insulin Resistance by Exacerbating Hepatic Steatosis in Male Wistar Rats

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Role of Resistin in Diet-Induced Hepatic Insulin Resistance

Journal of Clinical Investigation
Medicine
2004English

Thioesterase Superfamily Member 2 Promotes Hepatic Insulin Resistance in the Setting of Glycerol-3-Phosphate Acyltransferase 1-Induced Steatosis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Hypoxia-Inducible Factor Prolyl Hydroxylase 1 (PHD1) Deficiency Promotes Hepatic Steatosis and Liver-Specific Insulin Resistance in Mice

Scientific Reports
Multidisciplinary
2016English

Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis Through Brown and Beige Adipose Tissue Function

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2016English

Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy